デフォルト表紙
市場調査レポート
商品コード
1462978

経皮ドラッグデリバリーシステム市場、シェア、規模、動向、産業分析レポート:タイプ別、技術別、用途別、地域別、セグメント別予測、2024-2032年

Transdermal Drug Delivery Systems Market Share, Size, Trends, Industry Analysis Report, By Type (Transdermal Patches, Transdermal Semisolids); By Technology; By Application; By Region; Segment Forecast, 2024- 2032

出版日: | 発行: Polaris Market Research | ページ情報: 英文 115 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.49円
経皮ドラッグデリバリーシステム市場、シェア、規模、動向、産業分析レポート:タイプ別、技術別、用途別、地域別、セグメント別予測、2024-2032年
出版日: 2024年03月24日
発行: Polaris Market Research
ページ情報: 英文 115 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Research社の最新調査によると、経皮ドラッグデリバリーシステムの世界市場規模は2032年までに400億1,000万米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

ヘルスケア支出の増加と代替ドラッグデリバリー方法に対する意識の高まりが経皮ドラッグデリバリーシステム市場を促進しています。世界のヘルスケア支出の増加に伴い、患者の転帰を改善する費用対効果の高い治療に対するニーズが高まっています。経皮ドラッグデリバリーシステムは、従来の方法よりも優れているため、支持を集めています。経皮吸収型薬物送達システムは、薬物の放出を制御し持続させることで、有効性を高め、副作用を最小限に抑えることができます。非侵襲的で痛みを伴わない経皮パッチは、患者に快適さと服薬アドヒアランスを提供します。

処方箋なしで入手できるOTC(大衆薬)は、ちょっとした病気の自己治療にますます好まれています。便利な薬物療法の選択肢とセルフケアに対する需要の高まりにより、OTC市場は力強い成長を遂げています。経皮ドラッグデリバリーシステムは、OTC分野において、使いやすさや副作用の少なさなどの利点を提供します。消費者は自宅で簡単にパッチを貼ることができ、信頼性が高く便利な治療オプションを重視するOTC市場と一致しています。消費者の意識が高まり、より多くの製品が利用できるようになるにつれて、経皮ドラッグデリバリーシステムに対する需要は高まると予想されます。

経皮ホルモン補充療法(HRT)の選好が経皮ドラッグデリバリーシステム市場を牽引しています。更年期症状の緩和によく使われる経皮HRTは、従来の方法に比べて利点があります。経皮パッチは、消化器官や肝臓の代謝をバイパスして皮膚から直接ホルモンを投与するため、ホルモンレベルが安定し、副作用が軽減されます。便利で使いやすいパッチは、頻繁にヘルスケアを訪れる必要がなく、患者のコンプライアンスを促進します。控えめで快適なため、患者やヘルスケア提供者の間で人気が高まっています。

経皮ドラッグデリバリーシステム市場は、皮膚科や化粧品への応用拡大により成長しています。乾癬やにきびなどの症状をターゲットとし、全身的な副作用を最小限に抑えます。さらに、経皮パッチは、抗酸化剤やビタミンなどのスキンケア成分を送達するために、コスメシューティカルで人気が高まっています。これらのパッチは、放出が確実にコントロールされ、皮膚に長時間効果をもたらします。皮膚疾患の有病率の上昇、スキンケアに対する消費者の意識の高まり、非侵襲的なドラッグデリバリー方法の需要といった要因が、市場の成長を促進しています。

経皮ドラッグデリバリーシステム市場レポートハイライト

2023年には、使いやすさ、利便性、患者のコンプライアンスにより、経皮パッチ分野が大きな収益シェアを占めました。

2023年、イオントフォレーシス分野は、効率的なドラッグデリバリー、吸収促進、臨床採用の拡大により、大きな収益シェアを占めました。

2023年、疼痛管理分野は、慢性疼痛の発生率の増加、標的送達、患者の嗜好性により、大きな収益シェアを占めました。

2023年には、北米地域が、先進ヘルスケア・インフラ、高額医療費、主要市場プレイヤーの存在により、世界市場を独占しました。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界の経皮ドラッグデリバリーシステム市場の洞察

  • 経皮ドラッグデリバリーシステム市場- 用途スナップショット
  • 経皮ドラッグデリバリーシステムの市場力学
    • 促進要因と機会
      • 慢性疾患の罹患率の上昇により、製品の需要が増加すると予測されています。
      • 高齢化人口の増加により経皮ドラッグデリバリーシステム市場の成長が促進されると予想されている
    • 抑制要因と課題
      • 規制とコンプライアンスの要件が市場の成長を妨げる可能性が高い
  • PESTEL分析
  • 経皮ドラッグデリバリーシステム市場の用途動向
  • バリューチェーン分析
  • COVID-19の影響分析

第5章 技術別の世界市場

  • 主な調査結果
  • イントロダクション
  • イオントフォレシス
  • エレクトロポレーション
  • 超音波
  • 機械アレイ
  • その他

第6章 タイプ別の世界市場

  • 主な調査結果
  • イントロダクション
  • 経皮パッチ
  • 経皮吸収型半固形剤

第7章 用途別の世界市場

  • 主な調査結果
  • イントロダクション
  • 疼痛管理
  • ホルモンの応用
  • 心血管疾患
  • 中枢神経系疾患
  • その他

第8章 地域別の世界市場

  • 主な調査結果
  • イントロダクション
    • 経皮ドラッグデリバリーシステム市場評価、地域別、2019-2032年
  • 経皮ドラッグデリバリーシステム市場-北米
    • 北米:経皮ドラッグデリバリーシステム市場、技術別、2019年~2032年
    • 北米:経皮ドラッグデリバリーシステム市場、用途別、2019年~2032年
    • 北米:経皮ドラッグデリバリーシステム市場、タイプ別、2019年~2032年
    • 経皮ドラッグデリバリーシステム市場-米国
    • 経皮ドラッグデリバリーシステム市場- カナダ
  • 経皮ドラッグデリバリーシステム市場- 欧州
    • 欧州:経皮ドラッグデリバリーシステム市場、技術別、2019-2032年
    • 欧州:経皮ドラッグデリバリーシステム市場、用途別、2019-2032年
    • 欧州:経皮ドラッグデリバリーシステム市場、タイプ別、2019-2032年
    • 経皮ドラッグデリバリーシステム市場- 英国
    • 経皮ドラッグデリバリーシステム市場- フランス
    • 経皮ドラッグデリバリーシステム市場- ドイツ
    • 経皮ドラッグデリバリーシステム市場- イタリア
    • 経皮ドラッグデリバリーシステム市場- スペイン
    • 経皮ドラッグデリバリーシステム市場- オランダ
    • 経皮ドラッグデリバリーシステム市場- ロシア
  • 経皮ドラッグデリバリーシステム市場- アジア太平洋地域
    • アジア太平洋地域:経皮ドラッグデリバリーシステム市場、技術別、2019-2032年
    • アジア太平洋地域:経皮ドラッグデリバリーシステム市場、用途別、2019年~2032年
    • アジア太平洋地域:経皮ドラッグデリバリーシステム市場、タイプ別、2019年~2032年
    • 経皮ドラッグデリバリーシステム市場- 中国
    • 経皮ドラッグデリバリーシステム市場- インド
    • 経皮ドラッグデリバリーシステム市場- マレーシア
    • 経皮ドラッグデリバリーシステム市場- 日本
    • 経皮ドラッグデリバリーシステム市場- インドネシア
    • 経皮ドラッグデリバリーシステム市場- 韓国
  • 経皮ドラッグデリバリーシステム市場-中東およびアフリカ
    • 中東およびアフリカ:経皮ドラッグデリバリーシステム市場、技術別、2019-2032年
    • 中東およびアフリカ:経皮ドラッグデリバリーシステム市場、用途別、2019-2032年
    • 中東およびアフリカ:経皮ドラッグデリバリーシステム市場、タイプ別、2019-2032年
    • 経皮ドラッグデリバリーシステム市場- サウジアラビア
    • 経皮ドラッグデリバリーシステム市場-UAE
    • 経皮ドラッグデリバリーシステム市場- イスラエル
    • 経皮ドラッグデリバリーシステム市場- 南アフリカ
  • 経皮ドラッグデリバリーシステム市場-ラテンアメリカ
    • ラテンアメリカ:経皮ドラッグデリバリーシステム市場、技術別、2019年~2032年
    • ラテンアメリカ:経皮ドラッグデリバリーシステム市場、用途別、2019-2032年
    • ラテンアメリカ:経皮ドラッグデリバリーシステム市場、タイプ別、2019年~2032年
    • 経皮ドラッグデリバリーシステム市場- メキシコ
    • 経皮ドラッグデリバリーシステム市場- ブラジル
    • 経皮ドラッグデリバリーシステム市場- アルゼンチン

第9章 競合情勢

  • 拡大と買収の分析
    • 拡大
    • 買収
  • パートナーシップ/コラボレーション/契約/公開

第10章 企業プロファイル

  • 3M Company
  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Dr. Reddy's Laboratories Ltd.
  • Endo Pharmaceuticals Inc
  • GlaxoSmithKline plc
  • Hisamitsu Pharmaceutical Co., Inc.
  • Johnson & Johnson
  • MedPharm Ltd.
  • Mylan N.V.
  • Novartis International AG
  • Noven Pharmaceuticals, Inc.
  • Purdue Pharma L.P
  • Teva Pharmaceutical Industries Ltd.
  • UCB S.A.
図表

List of Tables

  • Table 1 Global Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
  • Table 2 Global Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
  • Table 3 Global Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
  • Table 4 Transdermal Drug Delivery Systems Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 5 North America: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
  • Table 6 North America: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
  • Table 7 North America: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
  • Table 8 U.S.: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
  • Table 9 U.S.: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
  • Table 10 U.S.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
  • Table 11 Canada: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
  • Table 12 Canada: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
  • Table 13 Canada: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
  • Table 14 Europe: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
  • Table 15 Europe: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
  • Table 16 Europe: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
  • Table 17 UK: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
  • Table 18 UK: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
  • Table 19 UK: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
  • Table 20 France: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
  • Table 21 France: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
  • Table 22 France: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
  • Table 23 Germany: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
  • Table 24 Germany: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
  • Table 25 Germany: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
  • Table 26 Italy: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
  • Table 27 Italy: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
  • Table 28 Italy: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
  • Table 29 Spain: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
  • Table 30 Spain: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
  • Table 31 Spain: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
  • Table 32 Netherlands: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
  • Table 33 Netherlands: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
  • Table 34 Netherlands: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
  • Table 35 Russia: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
  • Table 36 Russia: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
  • Table 37 Russia: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
  • Table 38 Asia Pacific: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
  • Table 39 Asia Pacific: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
  • Table 40 Asia Pacific: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
  • Table 41 China: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
  • Table 42 China: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
  • Table 43 China: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
  • Table 44 India: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
  • Table 45 India: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
  • Table 46 India: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
  • Table 47 Malaysia: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
  • Table 48 Malaysia: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
  • Table 49 Malaysia: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
  • Table 50 Japan: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
  • Table 51 Japan: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
  • Table 52 Japan: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
  • Table 53 Indonesia: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
  • Table 54 Indonesia: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
  • Table 55 Indonesia: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
  • Table 56 South Korea: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
  • Table 57 South Korea: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
  • Table 58 South Korea: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
  • Table 59 Middle East & Africa: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
  • Table 60 Middle East & Africa: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
  • Table 61 Middle East & Africa: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
  • Table 62 Saudi Arabia: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
  • Table 63 Saudi Arabia: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
  • Table 64 Saudi Arabia: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
  • Table 65 UAE: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
  • Table 66 UAE: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
  • Table 67 UAE: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
  • Table 68 Israel: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
  • Table 69 Israel: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
  • Table 70 Israel: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
  • Table 71 South Africa: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
  • Table 72 South Africa: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
  • Table 73 South Africa: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
  • Table 74 Latin America: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
  • Table 75 Latin America: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
  • Table 76 Latin America: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
  • Table 77 Mexico: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
  • Table 78 Mexico: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
  • Table 79 Mexico: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
  • Table 80 Brazil: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
  • Table 81 Brazil: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
  • Table 82 Brazil: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
  • Table 83 Argentina: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
  • Table 84 Argentina: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
  • Table 85 Argentina: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global Transdermal Drug Delivery Systems Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Type
  • Figure 7. Global Transdermal Drug Delivery Systems Market, by Type, 2022 & 2032 (USD Billion)
  • Figure 8. Market by Technology
  • Figure 9. Global Transdermal Drug Delivery Systems Market, by Technology, 2022 & 2032 (USD Billion)
  • Figure 10. Market by Application
  • Figure 11. Global Transdermal Drug Delivery Systems Market, by Application, 2022 & 2032 (USD Billion)
  • Figure 12. Transdermal Drug Delivery Systems Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Figure 13. Strategic Analysis - Transdermal Drug Delivery Systems Market
目次
Product Code: PM4660

The global transdermal drug delivery systems market size is expected to reach USD 40.01 billion by 2032, according to a new study by Polaris Market Research. The report "Transdermal Drug Delivery Systems Market Share, Size, Trends, Industry Analysis Report, By Type (Transdermal Patches, Transdermal Semisolids); By Technology; By Application; By Region; Segment Forecast, 2024- 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Rising healthcare spending and heightened awareness of alternative drug delivery methods are propelling the transdermal drug delivery systems market. With increasing global healthcare expenditures, there's a growing need for cost-effective treatments offering improved patient outcomes. Transdermal drug delivery systems are gaining traction for their advantages over conventional methods. They provide controlled, sustained medication release, enhancing efficacy and minimizing side effects. Non-invasive and painless, transdermal patches offer patient comfort and adherence.

OTC (Over-the-Counter) medications, available without a prescription, are increasingly preferred for self-treating minor ailments. With rising demand for convenient medication options and self-care, the OTC market is witnessing robust growth. Transdermal drug delivery systems offer advantages in the OTC sector, including ease of use and minimal side effects. Consumers can conveniently apply patches at home, aligning with the OTC market's focus on reliable and convenient treatment options. As consumer awareness increases and more products become available, the demand for transdermal drug delivery systems is expected to rise.

The preference for transdermal hormone replacement therapy (HRT) is driving the transdermal drug delivery systems market. Commonly used to alleviate menopausal symptoms, transdermal HRT offers advantages over traditional methods. Transdermal patches deliver hormones directly through the skin, bypassing the digestive system and liver metabolism, resulting in stable hormone levels and reduced side effects. Convenient and easy to use, patches promote patient compliance by eliminating frequent healthcare visits. Discreet and comfortable, they are increasingly popular among patients and healthcare providers.

The transdermal drug delivery systems market is growing due to expanding applications in dermatology and cosmeceuticals. It targets conditions like psoriasis and acne, minimizing systemic side effects. Additionally, transdermal patches are increasingly popular in cosmeceuticals for delivering skincare ingredients such as antioxidants and vitamins. These patches ensure controlled release, providing prolonged skin benefits. Factors like the rising prevalence of skin disorders, increasing consumer awareness about skincare, and demand for non-invasive drug delivery methods are driving the growth of the market.

Transdermal Drug Delivery Systems Market Report Highlights

In 2023, the transdermal patches segment held a significant revenue share owing to ease of use, convenience, and patient compliance.

In 2023, the iontophoresis segment held a significant revenue share owing to efficient drug delivery, enhanced absorption, and growing clinical adoption.

In 2023, the pain management segment held a significant revenue share owing to the growing incidence of chronic pain, targeted delivery, and patient preference.

In 2023, the North America region dominated the global market due to advanced healthcare infrastructure, high healthcare expenditure, and the presence of key market players.

The market is highly competitive owing to the existence of market players with a global presence, including Boehringer Ingelheim International GmbH, GlaxoSmithKline plc, Hisamitsu Pharmaceutical Co., Inc., Johnson & Johnson, MedPharm Ltd., Novartis International AG, and Purdue Pharma L.P. among others.

Polaris Market Research has segmented the Transdermal Drug Delivery Systems market report based on type, technology, application, and region:

Transdermal Drug Delivery Systems, Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Transdermal Patches
  • Transdermal Semisolids

Transdermal Drug Delivery Systems, Technology Outlook (Revenue - USD Billion, 2019 - 2032)

  • Iontophoresis
  • Electroporation
  • Ultrasound
  • Mechanical arrays
  • Others

Transdermal Drug Delivery Systems, Application Outlook (Revenue - USD Billion, 2019 - 2032)

  • Pain Management
  • Hormonal Applications
  • Cardiovascular Diseases
  • CNS Disorders
  • Others

Transdermal Drug Delivery Systems, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • France
  • Germany
  • UK
  • Italy
  • Netherlands
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • Japan
  • China
  • India
  • Malaysia
  • Indonesia
  • South Korea
  • Australia
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Transdermal Drug Delivery Systems Market Insights

  • 4.1. Transdermal Drug Delivery Systems Market - Application Snapshot
  • 4.2. Transdermal Drug Delivery Systems Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising prevalence of chronic diseases is projected to spur the product demand
      • 4.2.1.2. Growing Geriatric Population is expected to drive transdermal drug delivery systems market growth
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Regulatory and compliance requirements are likely to impede the market growth
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Transdermal Drug Delivery Systems Market Application Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Transdermal Drug Delivery Systems Market, by Technology

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
  • 5.3. Iontophoresis
    • 5.3.1. Global Transdermal Drug Delivery Systems Market, by Iontophoresis, by Region, 2019-2032 (USD Billion)
  • 5.4. Electroporation
    • 5.4.1. Global Transdermal Drug Delivery Systems Market, by Electroporation, by Region, 2019-2032 (USD Billion)
  • 5.5. Ultrasound
    • 5.5.1. Global Transdermal Drug Delivery Systems Market, by Ultrasound, by Region, 2019-2032 (USD Billion)
  • 5.6. Mechanical arrays
    • 5.6.1. Global Transdermal Drug Delivery Systems Market, by Mechanical arrays, by Region, 2019-2032 (USD Billion)
  • 5.7. Others
    • 5.7.1. Global Transdermal Drug Delivery Systems Market, by Others, by Region, 2019-2032 (USD Billion)

6. Global Transdermal Drug Delivery Systems Market, by Type

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
  • 6.3. Transdermal Patches
    • 6.3.1. Global Transdermal Drug Delivery Systems Market, by Transdermal Patches, by Region, 2019-2032 (USD Billion)
  • 6.4. Transdermal Semisolids
    • 6.4.1. Global Transdermal Drug Delivery Systems Market, by Transdermal Semisolids, by Region, 2019-2032 (USD Billion)

7. Global Transdermal Drug Delivery Systems Market, by Application

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
  • 7.3. Pain Management
    • 7.3.1. Global Transdermal Drug Delivery Systems Market, by Pain Management, By Region, 2019-2032 (USD Billion)
  • 7.4. Hormonal Applications
    • 7.4.1. Global Transdermal Drug Delivery Systems Market, by Hormonal Applications, By Region, 2019-2032 (USD Billion)
  • 7.5. Cardiovascular Diseases
    • 7.5.1. Global Transdermal Drug Delivery Systems Market, by Cardiovascular Diseases, By Region, 2019-2032 (USD Billion)
  • 7.6. CNS Disorders
    • 7.6.1. Global Transdermal Drug Delivery Systems Market, by CNS Disorders, By Region, 2019-2032 (USD Billion)
  • 7.7. Others
    • 7.7.1. Global Transdermal Drug Delivery Systems Market, by Others, By Region, 2019-2032 (USD Billion)

8. Global Transdermal Drug Delivery Systems Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Transdermal Drug Delivery Systems Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 8.3. Transdermal Drug Delivery Systems Market - North America
    • 8.3.1. North America: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
    • 8.3.2. North America: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
    • 8.3.3. North America: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
    • 8.3.4. Transdermal Drug Delivery Systems Market - U.S.
      • 8.3.4.1. U.S.: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
      • 8.3.4.2. U.S.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
      • 8.3.4.3. U.S.: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
    • 8.3.5. Transdermal Drug Delivery Systems Market - Canada
      • 8.3.5.1. Canada: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
      • 8.3.5.2. Canada.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
      • 8.3.5.3. Canada: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
  • 8.4. Transdermal Drug Delivery Systems Market - Europe
    • 8.4.1. Europe: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
    • 8.4.2. Europe.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
    • 8.4.3. Europe: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
    • 8.4.4. Transdermal Drug Delivery Systems Market - UK
      • 8.4.4.1. UK: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
      • 8.4.4.2. UK.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
      • 8.4.4.3. UK: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
    • 8.4.5. Transdermal Drug Delivery Systems Market - France
      • 8.4.5.1. France: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
      • 8.4.5.2. France.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
      • 8.4.5.3. France: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
    • 8.4.6. Transdermal Drug Delivery Systems Market - Germany
      • 8.4.6.1. Germany: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
      • 8.4.6.2. Germany.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
      • 8.4.6.3. Germany: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
    • 8.4.7. Transdermal Drug Delivery Systems Market - Italy
      • 8.4.7.1. Italy: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
      • 8.4.7.2. Italy.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
      • 8.4.7.3. Italy: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
    • 8.4.8. Transdermal Drug Delivery Systems Market - Spain
      • 8.4.8.1. Spain: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
      • 8.4.8.2. Spain.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
      • 8.4.8.3. Spain: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
    • 8.4.9. Transdermal Drug Delivery Systems Market - Netherlands
      • 8.4.9.1. Netherlands: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
      • 8.4.9.2. Netherlands.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
      • 8.4.9.3. Netherlands: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
    • 8.4.10. Transdermal Drug Delivery Systems Market - Russia
      • 8.4.10.1. Russia: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
      • 8.4.10.2. Russia.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
      • 8.4.10.3. Russia: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
  • 8.5. Transdermal Drug Delivery Systems Market - Asia Pacific
    • 8.5.1. Asia Pacific: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
    • 8.5.2. Asia Pacific.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
    • 8.5.3. Asia Pacific: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
    • 8.5.4. Transdermal Drug Delivery Systems Market - China
      • 8.5.4.1. China: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
      • 8.5.4.2. China.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
      • 8.5.4.3. China: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
    • 8.5.5. Transdermal Drug Delivery Systems Market - India
      • 8.5.5.1. India: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
      • 8.5.5.2. India.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
      • 8.5.5.3. India: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
    • 8.5.6. Transdermal Drug Delivery Systems Market - Malaysia
      • 8.5.6.1. Malaysia: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
      • 8.5.6.2. Malaysia.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
      • 8.5.6.3. Malaysia: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
    • 8.5.7. Transdermal Drug Delivery Systems Market - Japan
      • 8.5.7.1. Japan: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
      • 8.5.7.2. Japan.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
      • 8.5.7.3. Japan: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
    • 8.5.8. Transdermal Drug Delivery Systems Market - Indonesia
      • 8.5.8.1. Indonesia: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
      • 8.5.8.2. Indonesia.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
      • 8.5.8.3. Indonesia: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
    • 8.5.9. Transdermal Drug Delivery Systems Market - South Korea
      • 8.5.9.1. South Korea: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
      • 8.5.9.2. South Korea.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
      • 8.5.9.3. South Korea: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
  • 8.6. Transdermal Drug Delivery Systems Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
    • 8.6.2. Middle East & Africa.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
    • 8.6.3. Middle East & Africa: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
    • 8.6.4. Transdermal Drug Delivery Systems Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
      • 8.6.4.2. Saudi Arabia.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
    • 8.6.5. Transdermal Drug Delivery Systems Market - UAE
      • 8.6.5.1. UAE: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
      • 8.6.5.2. UAE.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
      • 8.6.5.3. UAE: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
    • 8.6.6. Transdermal Drug Delivery Systems Market - Israel
      • 8.6.6.1. Israel: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
      • 8.6.6.2. Israel.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
      • 8.6.6.3. Israel: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
    • 8.6.7. Transdermal Drug Delivery Systems Market - South Africa
      • 8.6.7.1. South Africa: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
      • 8.6.7.2. South Africa.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
      • 8.6.7.3. South Africa: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
  • 8.7. Transdermal Drug Delivery Systems Market - Latin America
    • 8.7.1. Latin America: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
    • 8.7.2. Latin America.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
    • 8.7.3. Latin America: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
    • 8.7.4. Transdermal Drug Delivery Systems Market - Mexico
      • 8.7.4.1. Mexico: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
      • 8.7.4.2. Mexico.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
      • 8.7.4.3. Mexico: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
    • 8.7.5. Transdermal Drug Delivery Systems Market - Brazil
      • 8.7.5.1. Brazil: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
      • 8.7.5.2. Brazil.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
      • 8.7.5.3. Brazil: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
    • 8.7.6. Transdermal Drug Delivery Systems Market - Argentina
      • 8.7.6.1. Argentina: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
      • 8.7.6.2. Argentina.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
      • 8.7.6.3. Argentina: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. 3M Company
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Bayer AG
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Boehringer Ingelheim International GmbH
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Dr. Reddy's Laboratories Ltd.
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Endo Pharmaceuticals Inc
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. GlaxoSmithKline plc
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Hisamitsu Pharmaceutical Co., Inc.
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Johnson & Johnson
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. MedPharm Ltd.
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Mylan N.V.
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Novartis International AG
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Noven Pharmaceuticals, Inc.
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. Purdue Pharma L.P
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development
  • 10.14. Teva Pharmaceutical Industries Ltd.
    • 10.14.1. Company Overview
    • 10.14.2. Financial Performance
    • 10.14.3. Product Benchmarking
    • 10.14.4. Recent Development
  • 10.15. UCB S.A.
    • 10.15.1. Company Overview
    • 10.15.2. Financial Performance
    • 10.15.3. Product Benchmarking
    • 10.15.4. Recent Development